#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Homocystinuria Colorectal adenocarcinoma Hypoparathyroidism Testicular leiomyosarcoma Liver transplant rejection Haematological malignancy Henoch-Schonlein purpura Endometrial cancer Autoimmune disorder Non-Hodgkin's lymphoma unspecified histology indolent Squamous cell carcinoma of head and neck Palmoplantar pustulosis Friedreich's ataxia Haemophilia A without inhibitors More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Life with Disease Von Willebrand’s disease – Life with Disease Turner’s syndrome – Life with Disease Hypereosinophilic syndrome – Life with Disease Hairy cell leukaemia – Basic Information Systemic sclerosis pulmonary – Diagnostics Mucopolysaccharidosis III – Diagnostics Isodicentric chromosome 15 syndrome Mantle cell lymphoma stage II – Diagnostics Epidermolysis bullosa – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Collagenase SILYMARIN Inupadenant Hydrochloride RO7795081 HAFNIUM OXIDE Nicotine Brexpiprazole EGANELISIB Azd5462 Azetukalner S-241656 Gt005 Clindamycin Palonosetron Arginine Milnacipran Hydrochloride Salbutamol Sulfate Ph. Eur. Golimumab 534 Abbv-668 More therapies…

    Learn about Your Condition

    Invasive breast carcinoma Primary amyloidosis Infant sedation Bladder cancer recurrent White matter lesion Rhabdomyosarcoma Corneal dystrophy Perthes disease Lyme disease Testicular germ cell tumour Paresis Coronary artery dissection Multiple sclerosis relapse Haematological infection Andersen-Tawil syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Universitari General De Catalunya

Hospital Universitari General De Catalunya

Carrer Pedro I Pons 1, Sant Cugat Del Valles, 08195, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

    Recruiting

    3 1 1
    Investigated Drugs:
    • Aflibercept
    Czechia Hungary Latvia Lithuania Poland Slovakia +1

  • FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Bulgaria Czechia France Germany Hungary Italy +3

  • A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

    Recruiting

    3 1
    Investigated Diseases:
    • Thrombocytopenia
    Bulgaria France Poland Romania Spain

  • A study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    Investigated Drugs:
    • Sodium Chloride
    Belgium France Germany Italy The Netherlands Spain

  • A study comparing prasinezumab with placebo for people with early-stage Parkinson’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria Denmark France Germany Italy The Netherlands +3

  • A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • RLY-2608
    • Capivasertib
    • Fulvestrant
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Study of Semaglutide on Embryo Quality in Overweight and Obese Women Undergoing In Vitro Fertilization for Infertility

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Follitropin Alfa
    • Ganirelix
    • Triptorelin
    Spain

  • Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Croatia Czechia France Germany Greece Italy +4

  • Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • IMEROPRUBART
    Czechia Denmark Germany Greece Hungary Italy +3

  • Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency
    Spain
1 2 3 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!